The headline for good: Remdesivir shows modest benefits in coronavirus trial.
The others: U.S. coronavirus death toll is far higher than reported, C.D.C. data suggests, N.Y. building sites reopen, carefully, in sign of life gearing back up, and Worst economy in a decade. What's next? 'Worst in our lifetime.'
Good morning.
Source: NY Times
Nenhum comentário:
Postar um comentário